Despite these finding offered a deeper understanding of the occurrence of angiogenesis in melanoma progression and provided promising targets, more clinical studies are necessary for estimating the therapeutic values of the HSP90/IKK enriched sEVs. This evidence concerns the gene HSP90AA1 and melanoma.